Ep. 50 - IgA Nephropathy: Exploring Treatment Advances and Managed Care Considerations скачать в хорошем качестве

Ep. 50 - IgA Nephropathy: Exploring Treatment Advances and Managed Care Considerations

This episode continues AMCP’s rare disease series with an in-depth look at IgA nephropathy (IgAN), a progressive autoimmune kidney disease that often goes undiagnosed until advanced stages. We speak with Ami Gopalan, Senior Vice President of Strategic Content and Growth Optimization at Precision AQ. As a patient living with IgAN, Ami brings both a professional and personal perspective to the discussion as we explore the disease’s silent progression, the burden it places on patients and families, the evolving treatment landscape, and how managed care can better incorporate patient value, clinical guidelines, and emerging evidence to support long-term outcomes. This podcast is supported by an independent medical education grant from Alexion and AstraZeneca Rare Disease. AMCP offers CPE for this podcast through December 31, 2026.For additional information and to claim credit, please visit: The Power of Partnership: Bridging Patients and Payers in IgA Nephropathy Management. https://amcplearn.org/content/podcast... Interested in being a guest or know an expert? Let us know! https://www.amcp.org/podcast